Expression of interleukin‐22 in rheumatoid arthritis: Potential role as a proinflammatory cytokine
Top Cited Papers
Open Access
- 7 April 2005
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 52 (4) , 1037-1046
- https://doi.org/10.1002/art.20965
Abstract
Objective Interleukin-22 (IL-22) is a novel cytokine of the IL-10 family. Although its pathophysiologic function is largely unknown, induction of acute-phase responses by IL-22 has suggested proinflammatory properties. In this study, we sought to examine whether IL-22 plays a role in the pathogenesis of rheumatoid arthritis (RA). Methods Expression of IL-22 and IL-22 receptor 1 (IL-22R1) was examined by reverse transcription–polymerase chain reaction (RT-PCR), Western blot, and immunohistochemical analysis. The effects of recombinant IL-22 (rIL-22) on cultured synovial fibroblasts derived from RA patients (RASF), with regard to the proliferation of synovial fibroblasts and production of monocyte chemoattractant protein 1 (MCP-1), were examined by alamer blue assay and enzyme-linked immunosorbent assay, respectively. Results IL-22 messenger RNA was detected by RT-PCR in RA synovial tissues and mononuclear cells isolated from RA synovial fluid samples. High levels of IL-22 were expressed both in the lining and the sublining layers of RA synovial tissues. Staining for vimentin and CD68, as markers of synovial fibroblasts and macrophages, respectively, showed that the majority of IL-22–positive cells were synovial fibroblasts and macrophages. IL-22R1 was also expressed in both the lining and the sublining layers of RA synovial tissues. The majority of cells expressing IL-22R1 were positive for vimentin, but not for CD68. Expression of IL-22 and IL-22R1 in RASF was confirmed by RT-PCR and Western blot analysis. In vitro, rIL-22 significantly increased proliferation of RASF and production of MCP-1 by RASF above the value of medium controls. Moreover, MAPK activation was induced in RASF in response to IL-22 stimulation. Conclusion These data suggest that IL-22, produced by synovial fibroblasts and macrophages, promotes inflammatory responses in RA synovial tissues by inducing the proliferation and chemokine production of synovial fibroblasts.Keywords
This publication has 20 references indexed in Scilit:
- Activin A induces cell proliferation of fibroblast‐like synoviocytes in rheumatoid arthritisArthritis & Rheumatism, 2003
- Genomic structure and inducible expression of the IL-22 receptor α chain in miceGenes & Immunity, 2003
- Interleukin-22 (IL-22) Activates the JAK/STAT, ERK, JNK, and p38 MAP Kinase Pathways in a Rat Hepatoma Cell LineJournal of Biological Chemistry, 2002
- Cutting Edge: Immune Cells as Sources and Targets of the IL-10 Family Members?The Journal of Immunology, 2002
- Published by Massachusetts Medical Society ,2001
- Identification of the Functional Interleukin-22 (IL-22) Receptor ComplexJournal of Biological Chemistry, 2001
- Interleukin (IL)-22, a Novel Human Cytokine That Signals through the Interferon Receptor-related Proteins CRF2–4 and IL-22RJournal of Biological Chemistry, 2000
- Human interleukin-10-related T cell-derived inducible factor: Molecular cloning and functional characterization as an hepatocyte-stimulating factorProceedings of the National Academy of Sciences, 2000
- Effect of IL-10 on collagen-induced arthritis in miceInflammation Research, 1996
- Immunoregulatory role of interleukin 10 in rheumatoid arthritis.The Journal of Experimental Medicine, 1994